AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
How a big biotech’s start-up gamble went wrong
Behind the Money
The Importance of Gene Sequencing Technology in Cancer Screening
Illumina's new acquisition, Grail, is a biotech startup that's in the process of developing another potentially revolutionary technology. What they're working on is a test that can screen for lots of different types of cancer by analyzing a person's blood. Picture what that could mean for Illumina, a company that would not only have a near monopoly on gene sequencing technology, but also a major cancer screening test.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode